Roche's IMpower130 Met Co-Primary Endpoints, Lifting ASCO Suspense

 
• By Sten Stovall
Doctor examining at lungs radiograph x-ray film of patient in operation room. medical concept.
Roche Says Tecentriq In IMpower130 Met OS and PFS Co-Primary Endpoints • Source: Shutterstock

More from Immuno-oncology

More from Anticancer